Literature DB >> 18422735

Clinical immunology review series: an approach to the patient with recurrent superficial abscesses.

S L Johnston1.   

Abstract

Patients may be referred to the immunology clinic for investigation of recurrent superficial abscess formation. In the majority of adult patients this clinical presentation does not equate with an underlying primary immune deficiency. Nevertheless, recurrent mucocutaneous abscesses can be associated with significant morbidity and long-term complications, including scarring and fistula formation, and may be associated with underlying immune-mediated disease. This review sets out an approach to the patient with recurrent superficial abscesses, focusing on the differential diagnoses, investigation and management of both the common causes and those associated with specific immune deficiency.

Entities:  

Mesh:

Year:  2008        PMID: 18422735      PMCID: PMC2453199          DOI: 10.1111/j.1365-2249.2008.03640.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  51 in total

Review 1.  Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies.

Authors: 
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

2.  Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program.

Authors:  A H Filipovich; J V Stone; S C Tomany; M Ireland; C Kollman; C J Pelz; J T Casper; M J Cowan; J R Edwards; A Fasth; R P Gale; A Junker; N R Kamani; B J Loechelt; D W Pietryga; O Ringdén; M Vowels; J Hegland; A V Williams; J P Klein; K A Sobocinski; P A Rowlings; M M Horowitz
Journal:  Blood       Date:  2001-03-15       Impact factor: 22.113

3.  Tuberculous gumma (cutaneous metastatic tuberculous abscess) with underlying lymphoma.

Authors:  V G Kalaria; R Kapila; R A Schwartz
Journal:  Cutis       Date:  2000-10

4.  Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab.

Authors:  F Martínez; P Nos; S Benlloch; J Ponce
Journal:  Inflamm Bowel Dis       Date:  2001-11       Impact factor: 5.325

5.  Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.

Authors:  M E Horwitz; A J Barrett; M R Brown; C S Carter; R Childs; J I Gallin; S M Holland; G F Linton; J A Miller; S F Leitman; E J Read; H L Malech
Journal:  N Engl J Med       Date:  2001-03-22       Impact factor: 91.245

6.  Capofungin therapy for Aspergillus lung infection in a boy with chronic granulomatous disease.

Authors:  Svea Sallmann; Antje Heilmann; Frank Heinke; Marie-Louise Kerkmann; Markus Schuppler; Gabriele Hahn; Manfred Gahr; Angela Rösen-Wolff; Joachim Roesler
Journal:  Pediatr Infect Dis J       Date:  2003-02       Impact factor: 2.129

7.  A case of cutaneous Mycobacterium chelonae abscessus infection in a renal transplant patient.

Authors:  C H Endzweig; E Strauss; F Murphy; B K Rao
Journal:  J Cutan Med Surg       Date:  2001 Jan-Feb       Impact factor: 2.092

Review 8.  Clinical immunology review series: an approach to the patient with recurrent infections in childhood.

Authors:  M A Slatter; A R Gennery
Journal:  Clin Exp Immunol       Date:  2008-03-28       Impact factor: 4.330

9.  Itraconazole to prevent fungal infections in chronic granulomatous disease.

Authors:  John I Gallin; David W Alling; Harry L Malech; Robert Wesley; Deloris Koziol; Beatriz Marciano; Eli M Eisenstein; Maria L Turner; Ellen S DeCarlo; Judith M Starling; Steven M Holland
Journal:  N Engl J Med       Date:  2003-06-12       Impact factor: 91.245

Review 10.  Sweet's syndrome revisited: a review of disease concepts.

Authors:  Philip R Cohen; Razelle Kurzrock
Journal:  Int J Dermatol       Date:  2003-10       Impact factor: 2.736

View more
  8 in total

1.  Recurrent cutaneous abscesses caused by PVL-MRSA.

Authors:  Marilina Antonelou; Jonathan Knowles; Shahab Siddiqi; Parveen Sharma
Journal:  BMJ Case Rep       Date:  2011-06-29

Review 2.  Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update.

Authors:  E de Vries
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

3.  Cutaneous Manifestations of Primary Immunodeficiency Diseases in Tunisian Children.

Authors:  Naouel Guirat Dhouib; Monia Ben Khaled; Monia Ouederni; Imen Ben-Mustapha; Ridha Kouki; Habib Besbes; Mohamed Ridha Barbouche; Fethi Mellouli; Mohamed Bejaoui
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-11-01       Impact factor: 2.576

4.  Incidence and recurrence of boils and abscesses within the first year: a cohort study in UK primary care.

Authors:  Laura J Shallcross; Andrew C Hayward; Anne M Johnson; Irene Petersen
Journal:  Br J Gen Pract       Date:  2015-10       Impact factor: 5.386

Review 5.  Sialic acids siglec interaction: a unique strategy to circumvent innate immune response by pathogens.

Authors:  Biswajit Khatua; Saptarshi Roy; Chitra Mandal
Journal:  Indian J Med Res       Date:  2013-11       Impact factor: 2.375

6.  Idelalisib impairs TREM-1 mediated neutrophil inflammatory responses.

Authors:  Astrid Alflen; Nicole Stadler; Pamela Aranda Lopez; Daniel Teschner; Matthias Theobald; Georg Heß; Markus P Radsak
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

7.  Pyoderma gangrenosum in a patient with chronic granulomatous disease: A case report.

Authors:  Sideris Nanoudis; Afroditi Tsona; Olga Tsachouridou; Petros Morfesis; Georgia Loli; Adamantini Georgiou; Pantelis Zebekakis; Symeon Metallidis
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

8.  Variable clinical characteristics and laboratory results in five patients with Chinese Good's syndrome (thymoma and hypogammaglobulinemia): an 8-year retrospective analysis in a university hospital in China.

Authors:  Jinyao Ni; Junwu Zhang; Yanxia Chen; Weizhong Wang; Jinlin Liu
Journal:  BMC Immunol       Date:  2021-08-03       Impact factor: 3.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.